| |
| |
|
| Insider
Information: |
Martin John C |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,895,138 |
|
|
Indirect Shares
|
2,684,281 |
|
|
| Direct
Value |
$186,589,533 |
|
|
|
Indirect Value
|
$47,040,306 |
|
|
| Total
Shares |
5,579,419 |
|
|
| Total
Value |
$233,629,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 14 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2015-09-01 |
4 |
OE |
$14.50 |
$2,175,375 |
D/D |
150,000 |
4,098,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2015-09-01 |
4 |
AS |
$101.81 |
$15,409,610 |
D/D |
(150,000) |
3,948,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2015-10-01 |
4 |
OE |
$14.50 |
$2,175,375 |
D/D |
150,000 |
4,098,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2015-10-01 |
4 |
AS |
$97.14 |
$14,622,289 |
D/D |
(150,000) |
3,948,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2015-11-02 |
4 |
OE |
$14.50 |
$2,175,375 |
D/D |
150,000 |
4,098,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2015-11-02 |
4 |
AS |
$109.02 |
$16,413,026 |
D/D |
(150,000) |
3,948,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2015-12-01 |
4 |
OE |
$14.50 |
$2,175,375 |
D/D |
150,000 |
4,098,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2015-12-01 |
4 |
AS |
$105.33 |
$15,873,467 |
D/D |
(150,000) |
3,948,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2016-08-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
156,714 |
3,131,096 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-03-03 |
4 |
S |
$40.01 |
$6,970,143 |
D/D |
(174,227) |
2,015,496 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2011-03-03 |
4 |
OE |
$8.22 |
$1,431,937 |
D/D |
174,227 |
2,086,990 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2014-03-06 |
4 |
D |
$79.92 |
$15,012,812 |
D/D |
(187,848) |
4,429,387 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
194,314 |
4,142,628 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2015-02-17 |
4 |
D |
$103.84 |
$25,358,247 |
D/D |
(244,205) |
4,255,876 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-02-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,287,706 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-02-01 |
4 |
AS |
$40.40 |
$11,410,477 |
D/D |
(282,242) |
4,005,464 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-03-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,288,674 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-03-01 |
4 |
AS |
$43.05 |
$12,176,063 |
D/D |
(282,242) |
4,006,432 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-04-01 |
4 |
AS |
$48.01 |
$13,633,534 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-04-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-05-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-05-01 |
4 |
AS |
$50.17 |
$14,160,956 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-06-03 |
4 |
AS |
$51.91 |
$14,912,871 |
D/D |
(282,242) |
4,057,121 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-06-03 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2013-07-01 |
4 |
OE |
$7.63 |
$2,154,212 |
D/D |
282,242 |
4,339,363 |
0 |
- |
|
367 Records found
|
|
Page 14 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
